GLP-1 Based Therapies

Columbia, Lexington, Orangeburg, Sumter, Camden, Newberry, and Aiken, SC.

Diabetes is a condition that affects millions of Americans and dramatically hinders their quality of life. If you suffer from diabetes, you understand how dangerous an illness it really is. As such, treating diabetes is big business for American pharmaceutical companies who are constantly searching for new ways of tackling the disease.

Unfortunately, it appears that a relatively recent form of treatment, GLP-1–based therapies, can cause significant and potentially lethal health issues, including pancreatic cancer.

If you or a loved one has suffered from health issues related to your use of GLP-1–based therapies to treat your type 2 diabetes, you should speak with one of our defective products lawyers immediately about your options.

How GLP-1–based therapies Can Injure You

Diabetes is caused in one of two ways: either your pancreas doesn’t produce enough insulin or your cells do not do an effective job of absorbing the insulin that is produced. GLP-1–based therapies are designed to treat the first cause.

GLP-1 is a naturally occurring hormone in your body that helps regulate blood-sugar levels. The body of a diabetic does not produce enough GLP-1. GLP-1–based therapies essentially act as primers for your body; specifically, for your pancreas. In a GLP-1–based therapy, the drug will get down to the base cells and induce the production of more GLP-1. It will also stimulate production of insulin in the pancreas.

However, a 2011 study in the journal Gastroenterology found that GLP-1–based therapies were linked with a dramatic increase in two dangerous pancreatic conditions: pancreatitis and pancreatic cancer.

Both of these conditions are significant and dangerous. Severe pancreatitis can cause death, and pancreatic cancer is one of the most lethal and untreatable forms of cancer.

If you or a loved one has suffered pancreatic damage after using a GLP-1–based therapy to treat your diabetes, you should speak with one of our personal injury lawyers about your options. You could be entitled to compensation.

Our personal injury lawyers can help walk you through the process needed to pursue a claim on your own behalf or on behalf of a loved one who suffered a wrongful death as a result of GLP-1–based therapy use. Our defective product lawyers have years of experience representing people who have been wronged by pharmaceutical companies and their dangerous drugs.

If you’re looking for a personal injury lawyer to pursue a claim based on your prescribed use of GLP-1–based therapies, please contact McWhirter, Bellinger and Associates, P.A., today for a free consultation. We serve clients in Camden, Sumter, Lexington, Newberry, Orangeburg, Columbia, and Aiken, South Carolina.


(1807 Hampton Street Columbia, South Carolina 29201)
(485 N. Lafayette Drive Sumter, South Carolina 29150)
(119 East Main Street Lexington, South Carolina 29072)
(919 Broad Street Camden, South Carolina 29020)
(104 Office Park Drive Orangeburg, South Carolina 29118)
(2203 Wilson Road Newberry, South Carolina 29108)
(231 Pendleton Street, NW Aiken, South Carolina 29801)